Research Article
Treatment Satisfaction and Quality of Life among Type 2 Diabetes Patients: A Cross-Sectional Study in West Bank, Palestine
Table 2
Medications history and manner of prescribing of antidiabetic drugs.
| Monotherapy | (number of patients) | % of patients |
| Metformin | 312 | 82.1 | Glibenclamide | 6 | 1.6 | Dapagliflozin | 12 | 3.2 | Glimepiride | 118 | 31.1 | Sitagliptin | 61 | 16.1 | Vildagliptin | 23 | 6.1 | Saxagliptin | 9 | 2.4 | | (number of patients) | % of patient | Metformin+Glibenclamide | 6 | 1.6 | Metformin+Dapagliflozin | 3 | .8 | Metformin+Glimepiride | 112 | 29.5 | Metformin+Sitagliptin | 52 | 13.7 | Metformin+Vildagliptin | 17 | 4.5 | Metformin+Saxagliptin | 6 | 1.6 | Metformin+Dapagliflozin+Sitagliptin | 3 | 0.8 | Metformin+Dapagliflozin+Vildagliptin | 3 | 0.8 | Metformin+Glimepiride+Vildagliptin | 3 | 0.8 | Metformin+Dapagliflozin+Glimepiride+Sitagliptin | 3 | 0.8 |
|
|